Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed

Cesium-131 Therapy Stops Human brain Cancers from Reoccuring in Treated Locations Where Previous Typical Procedures Failed Today – 13:04 GMT RICHLAND, WA, United States, through ETELIGIS INC., 12/01/2014 – – IsoRay Inc. (NYSE MKT: ISR), a clinical modern technology firm and inventor in brachytherapy and also clinical isotope applications, today [...] Read More